Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study

Abstract

Among immunocompromised patients evaluated in this study, progression toward tuberculosis was highest in HIV-infected individuals and was poorly predicted by TST or IGRAs. Clinical trial registered with www.clinicaltrials.gov (NCT 00707317).